期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

980 nm半导体激光治疗合并糖尿病的前列腺增生症疗效分析 被引量：6

下载PDF
导出
摘要 目的探讨经尿道980 nm半导体激光治疗合并糖尿病的前列腺增生症的效果。方法应用980 nm半导体激光系统治疗合并糖尿病的前列腺增生症患者32例,观察术中出血量、国际前列腺症状评分(IPSS)、膀胱残余尿量(RUV)及最大尿流率(Qmax)改变等指标的差异。结果 32例术中出血量(54±8)ml;术后随访6～24个月,IPSS由术前(26±6)分降至术后(10±4)分,Qmax由术前(5.6±2.8)ml/s增加至术后(18.5±4.6)ml/s,RUV由术前(210±26)ml降至术后(25±5)ml,手术前后比较差异均有统计学意义(P<0.05)。结论经尿道980 nm半导体激光汽化术是治疗合并糖尿病的前列腺增生症较好的方法。
作者 陈保春 史庆路 田龙江 杨青松 张洪博
机构地区 河北省沧州市人民医院泌尿外科
出处 《疑难病杂志》 CAS 2011年第5期376-377,共2页 Chinese Journal of Difficult and Complicated Cases
关键词 前列腺增生症 980 nm半导体激光 糖尿病
分类号 R699 [医药卫生—泌尿科学] R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献5

  • 1洪宝发,符伟军,蔡伟,杨勇,陈耀富,展洁,张翠娥.经尿道选择性绿激光前列腺汽化术治疗高龄高危良性前列腺增生[J].中华泌尿外科杂志,2006,27(1):43-45. 被引量：128
  • 2Gregg EW,Engel MM,Narayan V.Complications of diabetes in elderly people[J].BMJ,2002,325(7370):916-917.
  • 3Adler AL,Stratton IM,Neil HA,et al.Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes(UKPDS 36):prospective observational study[J].BMJ,2000,321(7258):412-419.
  • 4Erol A,Cam K,Tekin A,et al.High power diode laser vaporization of the prostate:preliminary results for benign prostatic hyperplasia[J].J Urol,2009,182(3):1078-1082.
  • 5Clemente-Ramos LM.High power 980 nm diode laser:preliminary results in the treatment of benign prostatic hyperplasia[J].Arch Esp Urol,2009,62(2):125-130.

二级参考文献10

  • 1洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量：90
  • 2Uchida T,Ohori M,Soh S,et al.Factors influencing morbidity in patients undergoing transurethral resection of the prostate.Urology,1999 ,53:98-105.
  • 3Anson K.Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol,2004,14:27-29.
  • 4Shingleton WB,Terrell F,Renfroe L,et al.Low-power vs high-power KTP laser:improved method of laser ablation of prostate.J Endourol,1999,13:49-52.
  • 5Hai MA,Malek RS.Photoselective vaporization of the prostate :initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.J Endourol,2003 ,17 :93-96.
  • 6Reich O,Bachmann A,Schneede P,et al.Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate.J Urol,2004,171 (6 Pt1) :2502-2504.
  • 7Malek RS,Kuntzman RS,Barrett DM.High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol,2000,163:1730-1733.
  • 8Te AE,Malloy TR,Stein BS,et al.Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia:12-month results from the first United States multicenter prospective trial.J Urol,2004,172(4 Pt 1) :1404-1408.
  • 9Larson TR.Current treatment options for benign prostatic hyperplasia and their impact on sexual function.Urology ,2003,61:692-698.
  • 10Wada S,Yoshimura R,Kyo M,et al.Comparative study of tran.surethral laser prostatectomy versus transurethral electroresection for benign prostatic hyperplasia.Int J Urol,2000 ,7 :373-377.

共引文献127

同被引文献81

  • 1王胜利,李继海.980nm半导体激光减压术治疗椎间盘突出症286例[J].中国康复理论与实践,2006,12(7):632-632. 被引量：5
  • 2Mc Connell JD,Roehrborn CG,Bautista OM,et al.The long-term effectof doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia[J].N Engl J Med,2003,349(25):2387-2398.
  • 3Parsons JK,Carter HB,Partin AW,et al.Metabolic factors associated with benign prostatic hyperplasia[J].J Clin Endocrinol Metab,2006,91(7):2562-2568.
  • 4Gupta A,Gupta S,Pavuk M,et al.Anthoropometric and metabolic factors and risk of benign prostatic hyperplasia:aprospective cohortstudy of Air Force eterans[J].Urlogy,2006,68(6):1198-1205.
  • 5Kim WT,Yun SJ,Choi YD,et al.Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels[J].J Korean Med Sci,2011,26(9):1214-1218.
  • 6Vikram A,Jena GB,Ramarao P.Increased cell proliferation and contractility of prostate in insulin resistantrats:linking hyperinsulinemia with benign prostate hyperplasia[J].The Prostate,2010,70(1):79-89.
  • 7Ozden C,Ozdal OL,Urgancloglu G,et al.The cotrelation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia[J].Eur Urol,2007,51(1):199-206.
  • 8Matsumoto S, Kawai Y, Oka M, et al. Bladder function in 1713-estradiol- induced nonbacterial prostatitis model in Wistar rat[ J ]. Int Urol Neph- rol,2013,45 (3) :749-754.
  • 9Thumbikat P, Shahrara S, Sobkoviak R, et al. Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory media- tors[J]. J Urol,2010,184(4) :1536-1542.
  • 10Kim HJ,Park JW,Cho YS,et al. Pathogenic role of HIF-lc~ in prostate hyperplasia in the presence of chronic inflammation [ J ]. Biochim Bio- phys Acta,2013,1832( 1 ) :183-194.

引证文献6

二级引证文献57

疑难病杂志
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部